Literature DB >> 13917924

Susceptibility of mice to bacterial endotoxin after modification of reticulo-endothelial function by simple lipids.

A E STUART, G N COOPER.   

Abstract

Entities:  

Keywords:  OLEIC ACID/pharmacology; RETICULOENDOTHELIAL SYSTEM/pharmacology; STEARATES/pharmacology; TOXINS AND ANTITOXINS/pharmacology

Mesh：

Substances：

Year:  1962        PMID： 13917924     DOI： 10.1002/path.1700830126

Source DB:  PubMed          Journal:  J Pathol Bacteriol        ISSN： 0368-3494


× No keyword cloud information.
  7 in total

1.  THE SPECIFICITY OF CELLULAR IMMUNITY.

Authors:  D F GRAY; R POOLE
Journal:  J Hyg (Lond)       Date:  1964-09

Review 2.  Use of mouse models to study the mechanisms and consequences of RBC clearance.

Authors:  E A Hod; S A Arinsburg; R O Francis; J E Hendrickson; J C Zimring; S L Spitalnik
Journal:  Vox Sang       Date:  2010-03-21       Impact factor: 2.144

3.  Impaired host resistance to endotoxin and malaria in polychlorinated biphenyl- and hexachlorobenzene-treated mice.

Authors:  L D Loose; J B Silkworth; K A Pittman; K F Benitz; W Mueller
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

4.  Hemoglobin increases mortality from bacterial endotoxin.

Authors:  D Su; R I Roth; M Yoshida; J Levin
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

5.  HOST-PARASITE RELATIONSHIPS AMONG GROUP A STREPTOCOCCI. 3. DEPRESSION OF RETICULOENDOTHELIAL FUNCTION BY STREPTOCOCCAL PYROGENIC EXOTOXINS.

Authors:  E E HANNA; D W WATSON
Journal:  J Bacteriol       Date:  1965-01       Impact factor: 3.490

6.  MODIFICATION OF HOST RESPONSES TO BACTERIAL ENDOTOXINS. I. SPECIFICITY OF PYROGENIC TOLERANCE AND THE ROLE OF HYPERSENSITIVITY IN PYROGENICITY, LETHALITY, AND SKIN REACTIVITY.

Authors:  D W WATSON; Y B KIM
Journal:  J Exp Med       Date:  1963-09-01       Impact factor: 14.307

7.  CHANGES IN THE LYMPHORETICULAR TISSUES OF MICE BEARING THE LANDSCHUETZ TUMOUR.

Authors:  A M ELHASSAN; A E STUART
Journal:  Br J Cancer       Date:  1965-06       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.